Modulatory interactions of resting-state brain functional connectivity in major depressive disorder

Código QR

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder

Zhe Tu,1–4,* Yuan Yuan Jia,2,5,* Tao Wang,2,3,* Hang Qu,2,3 Jun Xi Pan,2,3 Jie Jie,2,3 Xiao Yan Xu,2,3 Hai Yang Wang,2,3 Peng Xie1–3 1Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; 2Department of Neurology, the First Affiliated Hospi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tu Z, Jia YY, Wang T, Qu H, Pan JX, Jie J, Xu XY, Wang HY, Xie P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Major depressive disorder physiophysiological modulatory effects resting-state networks Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/365ef751396547438510f5e280713fad
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The impact of age of onset on amygdala intrinsic connectivity in major depression
por: Clark DL, et al.
Publicado: (2018)

Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen JJ, et al.
Publicado: (2018)

Abnormal Fractional Amplitude of Low-Frequency Fluctuation as a Potential Imaging Biomarker for First-Episode Major Depressive Disorder: A Resting-State fMRI Study and Support Vector Machine Analysis
por: Yujun Gao, et al.
Publicado: (2021)

Predictors of Major Depressive Disorder in Older People
por: Susana Sousa, et al.
Publicado: (2021)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD
por: Li G, et al.
Publicado: (2018)

Face Recognition Brain Functional Connectivity in Patients With Major Depression: A Brain Source Localization Study by ERP
por: Lei Lei, et al.
Publicado: (2021)

Disrupted Brain Entropy And Functional Connectivity Patterns Of Thalamic Subregions In Major Depressive Disorder
por: Xue SW, et al.
Publicado: (2019)

Potential Genetic Overlap Between Insomnia and Sleep Symptoms in Major Depressive Disorder: A Polygenic Risk Score Analysis
por: Lindsay M. Melhuish Beaupre, et al.
Publicado: (2021)

Childhood Emotional Neglect Is Associated With Low Social Support in Chinese Patients With Major Depressive Disorder
por: Xuemei Qin, et al.
Publicado: (2021)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Xue-Qin Wang, et al.
Publicado: (2021)

Identification of Gene Co-Expression Modules and Core Genes Related to Immune Disorders in Major Depression Disorder
por: Zhang L, et al.
Publicado: (2021)

Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
por: Sharareh Parami, et al.
Publicado: (2021)

Neuronal connectivity in major depressive disorder: a systematic review
por: Helm K, et al.
Publicado: (2018)

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui SW, et al.
Publicado: (2018)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich L, et al.
Publicado: (2018)

Atrophic Corpus Callosum Associated with Altered Functional Asymmetry in Major Depressive Disorder
por: Ran S, et al.
Publicado: (2020)

Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
por: F Kheirkhah, et al.
Publicado: (2010)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
por: Bo Q, et al.
Publicado: (2019)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Wei Zheng, et al.
Publicado: (2021)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang KD, et al.
Publicado: (2017)

Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases
por: Fuquan Zhang, et al.
Publicado: (2021)

Plasma complement component 4 increases in patients with major depressive disorder
por: Wei J, et al.
Publicado: (2017)

Neural Activation via Acupuncture in Patients With Major Depressive Disorder: A Functional Near-Infrared Spectroscopy Study
por: Tingyu Zhang, et al.
Publicado: (2021)

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
por: Bai S, et al.
Publicado: (2021)

MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
por: Miguel A. Ortega, et al.
Publicado: (2021)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Borjanka Batinic, et al.
Publicado: (2021)

Affective network and default mode network in depressive adolescents with disruptive behaviors
por: Kim SM, et al.
Publicado: (2015)

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder
por: Brown EC, et al.
Publicado: (2018)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita T, et al.
Publicado: (2016)

The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
por: Li G, et al.
Publicado: (2016)

Prevalence of Major Depressive Disorder and Correlates of Thoughts of Death, Suicidal Behaviour, and Death by Suicide in the Geriatric Population—A General Review of Literature
por: Gloria Obuobi-Donkor, et al.
Publicado: (2021)

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
por: Wang M, et al.
Publicado: (2019)

Comparing the Self- and External Assessment Versions of the HCL-33 as Screening Instruments for Bipolar Disorder in Older Depressed Patients
por: Xinqiao Zhang, et al.
Publicado: (2021)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura R, et al.
Publicado: (2017)

Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita M, et al.
Publicado: (2018)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020)